Reliance Industries Receives Credit Rating Reaffirmation from ICRA Limited

1 min read     Updated on 29 Jan 2026, 08:53 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Reliance Industries Limited announced that ICRA Limited has reaffirmed credit ratings for its debt instruments on January 29, 2026. The rating agency maintained '[ICRA]AAA (Stable)' for Non-convertible Debentures and '[ICRA]A1+' for Commercial Paper. The company notified BSE Limited, National Stock Exchange of India Limited, and international exchanges including Luxembourg Stock Exchange and Singapore Exchange Limited about this development.

31245815

*this image is generated using AI for illustrative purposes only.

Reliance Industries Limited has received a credit rating reaffirmation from ICRA Limited for its debt instruments, as announced on January 29, 2026. The rating agency maintained its existing ratings for both Non-convertible Debentures and Commercial Paper issued by the company.

Credit Rating Details

Reliance Industries informed the stock exchanges that ICRA Limited has reaffirmed the credit ratings through its press release dated January 29, 2026. The rating reaffirmation covers two key debt instruments of the company.

Instrument Type: Rating Reaffirmed
Non-convertible Debentures: [ICRA]AAA (Stable)
Commercial Paper: [ICRA]A1+

Regulatory Communication

The company formally communicated this development to both major Indian stock exchanges where its shares are listed. The notification was sent to BSE Limited, where Reliance Industries trades under scrip code 500325, and to the National Stock Exchange of India Limited, where it trades under the symbol RELIANCE.

Management Statement

Savithri Parekh, Company Secretary and Compliance Officer of Reliance Industries Limited, signed the official communication to the exchanges. The notification was digitally signed on January 29, 2026, at 19:42:59 +05'30', ensuring proper documentation and compliance with regulatory requirements.

International Exchange Notification

The company also extended its communication to international exchanges where it maintains listings. Copies of the rating reaffirmation were sent to:

  • Luxembourg Stock Exchange at 35A Boulevard Joseph II, L-1840 Luxembourg
  • Singapore Exchange Limited at 4 Shenton Way, #02-01 SGX Centre 2, Singapore 068807

The rating reaffirmation demonstrates the continued confidence of ICRA Limited in Reliance Industries' creditworthiness and financial stability across its debt instruments.

Historical Stock Returns for Reliance Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+3.22%+0.31%-11.75%-0.24%+9.95%+61.61%

Reliance Industries Receives NCLT Approval for SevenHills Healthcare Resolution Plan

1 min read     Updated on 29 Jan 2026, 05:22 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Reliance Industries Limited has received NCLT Amaravati Bench approval for the resolution plan of SevenHills Healthcare Private Limited. The plan was submitted by Capri Global Holdings Private Limited with Reliance Industries and Reliance Strategic Business Ventures Limited as Equity Support Providers under the Corporate Insolvency Resolution Process. The NCLT order was dated January 19, 2026, and the company received intimation on January 28, 2026.

31233169

*this image is generated using AI for illustrative purposes only.

Reliance Industries Limited has secured a significant regulatory approval for its involvement in the resolution of SevenHills Healthcare Private Limited. The National Company Law Tribunal (NCLT) Amaravati Bench has approved the resolution plan under the Corporate Insolvency Resolution Process, marking a key development in the healthcare sector consolidation.

NCLT Approval Details

The Hon'ble NCLT Amaravati Bench issued its approval order on January 19, 2026, which was subsequently uploaded to the NCLT website on January 28, 2026. The resolution plan was submitted by Capri Global Holdings Private Limited, with Reliance Industries Limited and Reliance Strategic Business Ventures Limited serving as the Equity Support Provider.

Parameter: Details
Approving Authority: NCLT Amaravati Bench
Order Date: January 19, 2026
Website Upload Date: January 28, 2026
Resolution Applicant: Capri Global Holdings Private Limited
Equity Support Provider: Reliance Industries Limited / Reliance Strategic Business Ventures Limited
Target Company: SevenHills Healthcare Private Limited

Corporate Insolvency Resolution Process

The approval comes under the Corporate Insolvency Resolution Process of the Insolvency and Bankruptcy Code, 2016. This regulatory framework provides a structured mechanism for resolving corporate insolvencies while maximizing the value of assets for all stakeholders.

Communication Timeline

Reliance Industries received official intimation about the NCLT approval from the resolution professional on January 28, 2026 at 7:13 p.m. (IST). The company promptly disclosed this information to the stock exchanges on January 29, 2026, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance

The disclosure was made to multiple stock exchanges where Reliance Industries shares are listed, including BSE Limited (Scrip Code: 500325), National Stock Exchange of India Limited (Trading Symbol: RELIANCE), Luxembourg Stock Exchange, and Singapore Exchange Limited. This demonstrates the company's commitment to maintaining transparency across all its listing jurisdictions.

Historical Stock Returns for Reliance Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+3.22%+0.31%-11.75%-0.24%+9.95%+61.61%

More News on Reliance Industries

1 Year Returns:+9.95%